Study of the Characteristics of the Vascular Wall in Pediatric Age

NCT06774586 · tracked via the Priya Life Science Italy tracker

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase

Observational

Started

2024-06-18

Last updated

2025-01-14

Condition(s) studied

Cardiovascular Diseases

Study summary

With this study, we want to investigate the characteristics of the blood vessel wall and study cardiovascular risk in children and adolescents, whether or not they have heart disease, by subjecting patient to a noninvasive diagnostic examination with an innovative medical device called VICORDER©.

Eligibility

Sex

ALL

Min age

6 Years

Max age

17 Years

Healthy volunteers

Inclusion Criteria: * Patients from 6 to 17 years of age (extremes included) being treated in the Outpatient Departments of Emergency Pediatrics or admitted to the Department of Emergency Pediatrics * Patient cooperation during the performance of the examination. * Obtaining informed consent from the parent/legal guardian Exclusion Criteria: * Behavioral disorders or severe cognitive retardation, extreme agitation, or other factors that may impair the proper performance of the examination. * Anatomical alterations or presence of device or local pathology that conflicts with the placement of the VICORDER© cuffs.

Primary outcome measure(s)

Check whether pediatric patients with CV risk factors have increased arterial stiffness compared with patients without risk factors. — through study completion, an average of 1 year
Check whether pediatric patients with CV risk factors have increased arterial stiffness compared with patients without risk factors.

Trial sites (1)

Facility	City	Region	Status
IRCCS Azienda Ospedaliero - Universitaria di Bologna, U.O. Pediatria d'Urgenza, Pronto Soccorso e Osservazione Breve ed Intensiva	Bologna	Italy	Recruiting

More IRCCS Azienda Ospedaliero-Universitaria di Bologna trials in Italy

Electronic Registry of Male Patients With Congenital Adrenal Hyperplasia 21-hydroxylase Deficiency Recruiting

Molecular Characterization of Patients With Acute Myeloid Leukemia and the Impact of Clonal Evolution in the Response to Therapeutic Treatments Recruiting

Transcriptomics as an Aid in the Histological Diagnosis of Acute Rejection After Liver Transplantation Recruiting

Predictive Value of SFlt-1/PlGF Ratio for the Diagnosis of Cardiovascular Disorders in the Puerperium: Pilot Study Active, not recruiting

Exercise and Diet Effects in Reducing Cardiovascular Risk in Kidney Transplant Recipients Recruiting

Other trials for the same condition

Relationship Between Lifestyle Indicators and Cardiovascular Clinical Parameters Recruiting

Advanced Imaging Holistic Omics Biobank Recruiting

Multicenter Evaluation of Patients Using LATITUDE Monitoring System Recruiting

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease Recruiting

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06774586 on ClinicalTrials.gov ↗ ← All trials in Italy